PE Tech Report

NEWSLETTER

Like this article?

Sign up to our free newsletter

Albion Ventures invests GBP1.5m in buyout of medical imaging firm Mirada

Albion Ventures is investing GBP1.5m into medical software company Mirada to fund its management buyout from Siemens.

Albion Ventures is investing GBP1.5m into medical software company Mirada to fund its management buyout from Siemens.

Mirada has developed software that allows medical images from multiple sources to be combined to provide greater clinical certainty in diagnosis and treatment of cancer.

Scanning from MRI, CT, PET or SPECT has specific advantages when imaging certain conditions, but each technology has limitations. For example: CT or MRI may be used to view anatomy or soft tissue whereas PET or SPECT typically image physiological function, such as tumour or brain disorder.

Mirada’s products are designed to allow images from multiple sources to be fused together to show, for example, not only that a cancer is present but also its precise location relative to bones or organs.

Mirada’s FusionXD product additionally allows scans from follow up visits to be compared to the original so that the clinician can quickly assess the progression of disease, or response to treatment. Fusing images provides surgeons or radiologists with a more complete picture, thereby improving the quality of information available when managing the patient’s condition.

Mirada is the third medical scanning firm that Albion Ventures has invested in following Dexela, which produces and 3D mammograms, and Forth Photoincs, which has developed technology that enhances diagnosis and treatment of cervical cancer.

David Gudgin, partner, Albion Ventures, says: ‘Healthcare is a focus of investment for us. Mirada as our third medical scanning investment demonstrates the advantages of the sector. All three companies operate in the high growth area of medical imaging in different clinical areas using differing technologies. We believe this is an attractive opportunity to re-establish an existing business with developed products, an existing reseller channel and high calibre staff.

Like this article? Sign up to our free newsletter

MOST POPULAR

FURTHER READING

Featured